No photo of Michael W Fried
Contact Expert

View Scopus Profile

Michael W Fried

    • 19690 Citations
    • 58 h-Index
    1989 …2020

    Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

    • 12 Similar Profiles
    Chronic Hepatitis C Medicine & Life Sciences
    Ribavirin Medicine & Life Sciences
    Hepacivirus Medicine & Life Sciences
    Hepatitis C Medicine & Life Sciences
    Therapeutics Medicine & Life Sciences
    Genotype Medicine & Life Sciences
    Interferons Medicine & Life Sciences
    Virus Diseases Medicine & Life Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Projects 1999 2020

    The Patient-Reported Outcomes Project of HCV-TARGET (PROP up TARGET)

    Stewart, P. W., Golin, C. E., Fried, M. W., Evon, D. M. & Reeve, B.

    Patient-Centered Outcomes Research Institute (PCORI)

    8/1/15 → 10/31/18

    Project: Research project

    Hepatitis C
    Therapeutics
    Health Expenditures
    Patient Reported Outcome Measures
    Patient Outcome Assessment

    Hepatitis B Research Network

    Fried, M. W., Evon, D. M., Darling, J. M. & McGivern, D.

    NIH National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDKD)

    9/30/08 → 5/31/20

    Project: Research project

    Hepatitis B
    Research
    Guidelines
    Therapeutics
    Chronic Hepatitis B

    MK5172-065 - A Phase III Double Blind Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects with Chronic HCV GT1, GT4 and GT6 Infection with Inherited Blood Disorders with and without HIV Co-Infection

    Fried, M. W.

    Industry Sponsor

    12/10/14 → 12/9/17

    Project: Research project

    Impact of antiretroviral therapy on liver fibrosis in Zambian HIV/HBV patients

    Fried, M. W.

    NIH Fogarty International Center for Advanced Study in the Health Sciences

    9/1/14 → 8/31/15

    Project: Research project

    Hepatitis B virus
    Liver Cirrhosis
    HIV
    Mentors
    Africa South of the Sahara

    A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination in Subjects with Chronic HCV Infection and Child-Pugh Class B Cirrhosis

    Fried, M. W.

    Industry Sponsor

    8/27/14 → 8/26/17

    Project: Research project

    Research Output 1989 2017

    5 Citations

    Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: Results of the real-world, clinical practice HCV-TARGET study

    Welzel, T. M., Nelson, D. R., Morelli, G., Di Bisceglie, A., Reddy, R. K., Kuo, A., Lim, J. K., Darling, J., Pockros, P., Galati, J. S., Frazier, L. M., Alqahtani, S., Sulkowski, M. S., Vainorius, M., Akushevich, L., Fried, M. W. & Zeuzem, S. Oct 1 2017 In : Gut. 66, 10, p. 1844-1852 9 p.

    Research output: Contribution to journal › Article

    Ribavirin
    Genotype
    Safety
    Infection
    Fibrosis
    5 Citations

    Ledipasvir–sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders

    Walsh, C. E., Workowski, K., Terrault, N. A., Sax, P. E., Cohen, A., Bowlus, C. L., Kim, A. Y., Hyland, R. H., Han, B., Wang, J., Stamm, L. M., Brainard, D. M., McHutchison, J. G., von Drygalski, A., Rhame, F., Fried, M. W., Kouides, P., Balba, G. & Reddy, K. R. Mar 1 2017 In : Haemophilia. 23, 2, p. 198-206 9 p.

    Research output: Contribution to journal › Article

    Ribavirin
    Chronic Hepatitis C
    Hemorrhage
    Genotype
    Infection
    3 Citations

    HCV Council - critical appraisal of data: Recommendations for clinical practice in a rapidly evolving therapeutic landscape

    Reau, N., Fried, M. W., Nelson, D. R., Brown, R. S., Everson, G. T., Gordon, S. C., Jacobson, I. M., Lim, J. K., Pockros, P. J., Reddy, K. R. & Sherman, K. E. Apr 1 2016 In : Liver International. 36, 4, p. 488-502 15 p.

    Research output: Contribution to journal › Article

    Hepacivirus
    Expert Testimony
    Chronic Hepatitis C
    Therapeutics
    Hepatitis C

    High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity

    Johansson, S., Talloen, W., Tuefferd, M., Darling, J., Fanning, G., Fried, M. W. & Aerssens, J. Mar 1 2016 In : Liver International. 36, 3, p. 344-352 9 p.

    Research output: Contribution to journal › Article

    Ribavirin
    Hepacivirus
    Genotype
    Chemokines
    Dipeptidyl Peptidase 4
    53 Citations

    Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network

    Brown, R. S., O'Leary, J. G., Reddy, K. R., Kuo, A., Morelli, G. J., Burton, J. R., Stravitz, R. T., Durand, C., Di Bisceglie, A. M., Kwo, P., Frenette, C. T., Stewart, T. G., Nelson, D. R., Fried, M. W. & Terrault, N. A. Jan 1 2016 In : Liver Transplantation. 22, 1, p. 24-33 10 p.

    Research output: Contribution to journal › Article

    Therapeutic Human Experimentation
    Hepatitis C
    Interferons
    Registries
    Genotype